Description
VX-765isaninhibitorofNLRP3inflammasomeactivity;itinhibitscaspase1andIL-1βcleavageandrelease.VX-765exhibitsanti-inflammatory,antidepressant,andantiepilepticactivities.Invivo,thiscompounddecreasesIL-1βlevelsandattenuatesstress-induceddepression-likebehaviors.Inanimalmodelsofstatusepilepticus,VX-765decreasescellloss.Inothersimilaranimalmodels,thiscompounddecreaseschronicepilepticactivityanddelaysonsetofacuteseizures.
References
ZhangY,LiuL,LiuYZ,etal.NLRP3InflammasomeMediatesChronicMildStress-inducedDepressioninMiceviaNeuroinflammation.IntJNeuropsychopharmacol.2015Jan20.[Epubaheadofprint].PMID:25603858.
KaminskiRM,RogawskiMA,KlitgaardH.Thepotentialofantiseizuredrugsandagentsthatactonnovelmoleculartargetsasantiepileptogenictreatments.Neurotherapeutics.2014Apr;11(2):385-400.PMID:24671870.
NoeFM,PolascheckN,FrigerioF,etal.PharmacologicalblockadeofIL-1β/IL-1receptortype1axisduringepileptogenesisprovidesneuroprotectionintworatmodelsoftemporallobeepilepsy.NeurobiolDis.2013Nov;59:183-93.PMID:23938763.
MarosoM,BalossoS,RavizzaT,etal.Interleukin-1βbiosynthesisinhibitionreducesacuteseizuresanddrugresistantchronicepilepticactivityinmice.Neurotherapeutics.2011Apr;8(2):304-15.PMID:21431948.